Salmonid fish viruses and cell interactions at early steps of the infective cycle.
A flow cytometric virus-binding assay that directly visualizes the binding and entry of infectious pancreatic necrosis virus (IPNV), infectious haematopoietic necrosis virus (IHNV) and virus haemorrhagic septicaemia virus (VHSV) to several cell lines was established. The highest efficiency of binding was shown by the BF-2 cell line and this was used to study, at the attachment level, the interactions of these cells with salmonid fish viruses in coinfections, and to further determine if the earliest stage of the viral growth cycle could explain the previously described loss of infectivity of IHNV when IPNV is present. Our results demonstrated that IPNV binds to around 88% of cells either in single or dual infections, whereas IHNV attachment always decreased in the presence of any of the other viruses. VHSV binding was not affected by IPNV, but coinfection with IHNV reduced the percentage of virus-binding cells, which suggests competition for viral receptors or co-receptors. Internalization of the adsorbed IHNV was not decreased by coinfection with IPNV, so the hypothetical competence could be restricted to the binding step. Treatment of the cells with antiviral agents, such as amantadine or chloroquine, did not affect the binding of IPNV and VHSV, but reduced IHNV binding by more than 30%. Tributylamine affected viral binding of the three viruses to different degrees and inhibited IPNV or IHNV entry in a large percentage of cells treated for 30 min. Tributylamine also inhibited IHNV cytopathic effects in a dose-dependent manner, decreasing the virus yield by 4 log of the 50% endpoint titre, at 10 mm concentration. IPNV was also inhibited, but at a lower level. The results of this study support the hypothesis that IHNV, in contrast to VHSV or IPNV, is less efficient at completing its growth cycle in cells with a simultaneous infection with IPNV. It can be affected at several stages of viral infection and is more sensitive to the action of antiviral compounds.
de las Heras
A I
AI
Departamento de Microbiología Molecular, Consejo Superior de Investigaciones Científicas, Centro de Investigaciones Biológicas, Laboratorio de Virología, Madrid, Spain.
Rodríguez Saint-Jean
S
S
Pérez-Prieto
S I
SI
D000818:Animals; D002460:Cell Line; D006867:Hydrolases / Q000494:pharmacology; D029142:Infectious hematopoietic necrosis virus / Q000187:drug effects / Q000502:physiology; D018061:Infectious pancreatic necrosis virus / Q000187:drug effects / Q000502:physiology; D029141:Novirhabdovirus / Q000187:drug effects / Q000502:physiology; D012327:RNA Virus Infections / Q000473:pathology / Q000662:veterinary* / Q000821:virology; D012328:RNA Viruses / Q000187:drug effects / Q000502:physiology*; D012487:Salmonidae / Q000821:virology*; D053585:Virus Attachment / Q000187:drug effects
D006867:Hydrolases